Professor
Oregon State University
Gaurav Sahay is Professor in the Department of Pharmaceutical Sciences and co-Director for the Center of Innovative Drug Delivery and Imaging (CIDDI), at the College of Pharmacy at Oregon State University. Dr. Sahay’s lab is developing novel nanotechnology-based platforms including lipid-based nanoparticles for effective delivery of messenger RNA therapeutics for treatment of cystic fibrosis, retinal degeneration and against SARS-CoV2. He has done pioneering work to dissect the intracellular transport essential for nucleic acid delivery to the cytosol and developed methods to overcome endosomal barriers. He has more than 65-peer-reviewed publications in top tier journals including Science Advances, Nature, Nature Communications, Nature Biotechnology, Nature Nanotechnology, Journal of Controlled Release, Nano Letters etc. He is the winner of a 2013 American Association of Pharmaceutical Scientists (AAPS) Postdoctoral Fellow Award and serves as the Principal Investigator on awards funded through the National Institutes of Health, Cystic Fibrosis Foundation etc. He is co-founder of Enterx Bio and RNAvax Bio. Dr. Sahay completed his postdoctoral research with Prof. Robert Langer and Prof. Daniel Anderson at the Koch Institute for Integrative Cancer Research at MIT and received his Ph.D. from the University of Nebraska Medical Center under the mentorship of Prof. Alexander Kabanov.
Disclosure information not submitted.
The Quest for Next Generation Lipid Nanoparticles for Cell-Specific Delivery of mRNA
Thursday, May 16, 2024
10:20 AM – 10:40 AM PT
Thursday, May 16, 2024
10:40 AM – 11:00 AM PT